FeesSafety
Pluang+

Singaporean pleads guilty in $240M Bitcoin theft via Gemini impersonation scheme

Market News
07 Sep 2026, 20:32 WIB
Crypto Briefing
View Source
Bearish
Singaporean pleads guilty in $240M Bitcoin theft via Gemini impersonation scheme

Malone Lam, a 22-year-old Singaporean, pleaded guilty to helping steal over 4,100 Bitcoin worth $240 million by impersonating Gemini exchange and Google representatives. The scheme targeted a wealthy Washington investor through social engineering, convincing him to hand over security credentials. This case is notable as the first Bitcoin theft prosecuted under the RICO Act, involving 18 indicted individuals and highlighting risks of crypto scams despite strong technical security. Lam faces a minimum 14-year prison sentence, with prosecutors framing the operation as organized crime.

More News

DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.

DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.

DeGen Medical has filed a motion to dismiss key parts of a patent infringement lawsuit from Carlsmed, which claims DeGen's patient-specific spinal implants infringe on eight patents. DeGen argues that the contested patents cover abstract, computer-im...

Market News
Neutral
56 minutes ago
SoFi projects 50% earnings growth in 2027 and no need for new capital raises.

SoFi projects 50% earnings growth in 2027 and no need for new capital raises.

SoFi announced it expects about 50% growth in earnings for 2027, signaling strong financial performance ahead. The company also stated it will not need to raise new capital, indicating confidence in its current funding and business model. This outloo...

Company Fundamentals
Bullish
2 hours ago
China includes Ascentage Pharma's lisaftoclax and renews olverembatinib coverage in 2026 National Reimbursement Drug List

China includes Ascentage Pharma's lisaftoclax and renews olverembatinib coverage in 2026 National Reimbursement Drug List

Ascentage Pharma announced that its cancer drugs lisaftoclax and olverembatinib are now covered by China's 2026 National Reimbursement Drug List (NRDL), effective January 1, 2027. Lisaftoclax is newly included for treating chronic lymphocytic leukemi...

Market News
Bullish
5 hours ago
Jupiter (JUP) price correction halts near key support, signaling potential rebound if it surpasses $0.274.

Jupiter (JUP) price correction halts near key support, signaling potential rebound if it surpasses $0.274.

Jupiter (JUP) trades at $0.263, about 30% below its 12-month high and 92% above its low. The recent price correction stopped near the 200-day moving average at $0.242, a critical support level that buyers defended twice. For a trend reversal, JUP mus...

Technical Signals
Neutral
5 hours ago
Bitcoin drops below 200-week average amid extreme fear and ETF outflows, with no clear cause identified.

Bitcoin drops below 200-week average amid extreme fear and ETF outflows, with no clear cause identified.

Bitcoin recently fell 4.4% below its 200-week moving average, a rare event that coincides with a Fear and Greed Index reading of 10, signaling extreme market fear. Michael Saylor highlighted these metrics but did not link them directly to the price d...

Market News
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App